CSIMarket
 


Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 


Kymera Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



KYMR Gross Profit Margin (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Revenue Change -48.43 % -38.43 % - 39.93 % -
Seq. Revenue Change -17.05 % 19.66 % -52.68 % 9.81 % -0.98 %
Revenue In Millions $9.55 $11.51 $9.62 $20.34 $18.52
Gross Profit Margin - - - - -
Gross Profit Margin Total Ranking # 781 # 777 # 830 # # 798
Gross Profit In Millions $9.55 $11.51 $9.62 $20.34 $18.52
Y / Y Gross Profit Change - - - - -
Seq. Gross Profit Change - - - - -


Commenting Third Quarter 2022 Gross Profit Margin
Kymera Therapeutics Inc experienced contraction in Gross Profit by -17.05 % to $10 millions and Revenue by -17.05 %, while Gross Profit Margin fell to 100 % a new company low.

Observing third quarter 2022 results within Biotechnology & Pharmaceuticals industry 56 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated compare to previous quarter from 777 to 781.
Learn about Gross Margin
KYMR's Gross Profit Margin third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 57
Healthcare Sector # 205
Overall # 781

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Sep 30 2022)  




Other Gross Profit Margin Profitability Ratios
KYMR's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
KYMR's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for KYMR's Competitors
Gross Profit Margin Profit Margin for Kymera Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for KYMR's Customers

You may also want to know
KYMR's Annual Growth Rates KYMR's Profitability Ratios KYMR's Asset Turnover Ratio KYMR's Dividend Growth
KYMR's Roe KYMR's Valuation Ratios KYMR's Financial Strength Ratios KYMR's Gross Profit Growth
KYMR's Roa KYMR's Inventory Turnover Ratio KYMR's Growth Rates KYMR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginSep 30 2022 MRQ Gross ProfitSep 30 2022 MRQ Revenue
Anavex Life Sciences Corp   106.83 %$ 2.348 $ 2.198 
Adaptimmune Therapeutics Plc  100.00 %$ 7.331 $ 7.331 
Edoc Acquisition Corp   100.00 %$ 0.101 $ 0.101 
Alector Inc   100.00 %$ 14.852 $ 14.852 
Aligos Therapeutics Inc   100.00 %$ 4.106 $ 4.106 
Allogene Therapeutics Inc   100.00 %$ 0.049 $ 0.049 
Armata Pharmaceuticals Inc   100.00 %$ 1.338 $ 1.338 
Atara Biotherapeutics Inc   100.00 %$ 4.459 $ 4.459 
Biocardia Inc  100.00 %$ 0.212 $ 0.212 
Beam Therapeutics Inc   100.00 %$ 15.799 $ 15.799 
Bluebird Bio Inc   100.00 %$ 0.071 $ 0.071 
Candel Therapeutics Inc   100.00 %$ 0.031 $ 0.031 
C4 Therapeutics Inc   100.00 %$ 6.754 $ 6.754 
Codiak Biosciences Inc   100.00 %$ 0.522 $ 0.522 
Cardio Diagnostics Holdings Inc   100.00 %$ 0.000 $ 0.000 
Celldex Therapeutics inc   100.00 %$ 0.407 $ 0.407 
Caribou Biosciences Inc   100.00 %$ 3.303 $ 3.303 
Cardiff Oncology inc   100.00 %$ 0.551 $ 0.551 
Curis Inc   100.00 %$ 2.825 $ 2.825 
Crispr Therapeutics Ag  100.00 %$ 0.094 $ 0.094 
Dbv Technologies S a   100.00 %$ 2.074 $ 2.074 
Precision Biosciences Inc  100.00 %$ 7.363 $ 7.363 
Editas Medicine inc   100.00 %$ 0.042 $ 0.042 
Eyepoint Pharmaceuticals Inc   100.00 %$ 10.012 $ 10.012 
Fate Therapeutics Inc   100.00 %$ 14.981 $ 14.981 
4d Molecular Therapeutics Inc   100.00 %$ 0.500 $ 0.500 
Homology Medicines Inc  100.00 %$ 0.802 $ 0.802 
Finch Therapeutics Group Inc   100.00 %$ 0.138 $ 0.138 
Fresh Tracks Therapeutics Inc   100.00 %$ 0.486 $ 0.486 
Fusion Pharmaceuticals Inc   100.00 %$ 0.166 $ 0.166 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TRER's Profile

Stock Price

TRER's Financials

Business Description

Fundamentals

Charts & Quotes

TRER's News

Suppliers

TRER's Competitors

Customers & Markets

Economic Indicators

TRER's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071